Lv3
240 积分 2023-09-13 加入
Telitacicept: A novel horizon in targeting autoimmunity and rheumatic diseases
10天前
已完结
Varespladib and Cardiovascular Events in Patients With an Acute Coronary Syndrome
1个月前
已完结
Updated Cost-effectiveness Assessments of PCSK9 Inhibitors From the Perspectives of the Health System and Private Payers
2个月前
已完结
Comprehensive Assessment of PCSK9 Inhibitors for Lipid Management: Scientific Guidance Based on Drug Selection Recommendations for Chinese Medical Institutions
2个月前
已完结
Cost-effectiveness analysis of PCSK9 inhibitors in cardiovascular diseases: a systematic review
2个月前
已完结
Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients
2个月前
已完结
Mineralocorticoid receptor antagonists in diabetic kidney disease — mechanistic and therapeutic effects
3个月前
已完结
Pleiotropic effects of statins: New evidences
4个月前
已关闭
Selatogrel: A Novel Subcutaneous P2Y12 Inhibitor
4个月前
已完结
Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque
4个月前
已完结
皖公网安备34019202002308
